Pharmacology Watch
RSSArticles
-
Study: Idarucizumab Safely Reverses Anticoagulant Effect of Dabigatran
Promising evidence emerges about the efficacy of the first reversal agent for one of the non-vitamin K oral anticoagulants.
-
How Long Should Patients Take Antibiotics?
Researchers from the United Kingdom proclaim 'the antibiotic course has had its day.'
-
Using Tramadol to Treat Opioid Withdrawal
The authors of a recent study found that the use of tramadol to treat opioid withdrawal symptoms was associated with fewer withdrawal symptoms compared to clonidine and was comparable to buprenorphine.
-
Federal Regulators Address Opioid Crisis
FDA says reducing the scope of the epidemic of opioid addiction is the agency's highest immediate priority.
-
Report: 92 Million American Adults Used Prescription Opioids in 2015
Of those, 11.5 million people misused opioids, and nearly 2 million adults suffered from an opioid use disorder.
-
FDA Actions
In this section: New FDA commissioner off to fast start on opioids, drug safety, and orphan drug designation.
-
Comparing Insulin Treatments for Diabetic Patients
Authors of two studies suggested that 32 weeks’ treatment with insulin degludec vs. insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemic episodes.
-
Exploring the Rising Prices of Generic Drugs
Study: As competition among generic drugs decreases, prices go up.
-
Investigators Tackle Antimicrobial Resistance
Researchers suggested that “modified use of antimicrobial agents and public health interventions, coupled with novel antimicrobial strategies, may help mitigate the effect of multidrug-resistant organisms in the future.”
-
Antibiotics for Upper Respiratory Infections in Elderly Patients
Physicians who were more likely to prescribe an antibiotic for an acute upper respiratory tract infection included mid- and late-career physicians, physicians trained outside of Canada or the United States, and high-volume physicians.